Lorazepam

Product NDC
68071-2662
11-digit product format
680712662
Labeler code
68071
Product ID
68071-2662_db4a3ca5-d499-6f75-e053-2995a90a1f94
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lorazepam
Dosage form
TABLET
Route
ORAL
Labeler
NuCare Pharmaceuticals,Inc.
Application
ANDA072926
Marketing category
ANDA
Marketing start
2021-10-11
Marketing end
0000-00-00
Substance
LORAZEPAM
Active strength
1 mg/1
Pharmacologic classes
Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
O26FZP769LLORAZEPAM846-49-1LORAZEPAM

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68071-2662-36807126620330 TABLET in 1 BOTTLE, PLASTIC (68071-2662-3) 30 tablet2022-03-280000-00-00NoNoCurrent
68071-2662-46807126620445 TABLET in 1 BOTTLE, PLASTIC (68071-2662-4) 45 tablet2022-03-280000-00-00NoNoCurrent
68071-2662-66807126620660 TABLET in 1 BOTTLE, PLASTIC (68071-2662-6) 60 tablet2022-03-280000-00-00NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Lorazepam Tablets, USP C-IVNuCare Pharmaceuticals,Inc.2022-03-28HUMAN PRESCRIPTION DRUG LABEL1